Literature DB >> 10069405

Improving outcomes in elderly patients with asthma.

D S Renwick1, M J Connolly.   

Abstract

Although often regarded as a disease of childhood, asthma is common in elderly people. Although recent figures show a decline over the past few years in the number of asthma deaths in children and younger adults, the same is not true of older adults, in whom most asthma deaths occur. Differences between asthma in young and old patients are seen not only in response to treatment. The nonspecific presentation of asthma in elderly adults means that the diagnosis of asthma is difficult to make. In addition, research suggests that physicians are reluctant to use spirometry and measurement of reversibility when investigating respiratory symptoms in old people. This leads to a tendency to label breathless or wheezy elderly patients as having chronic obstructive pulmonary disease (COPD) rather than asthma. In turn, patients with a diagnosis of COPD are less likely to be treated with bronchodilators and corticosteroids. Treatment guidelines for the management of asthma in children and younger adults may need to be adapted when applied to older patients. Reduced perception of bronchoconstriction may lead to underuse of bronchodilators prescribed 'as required'. The bronchodilator response to beta2-agonists is attenuated as part of the normal aging process, and other groups of bronchodilator medications should be considered. Inhaler technique can be a particular problem in elderly patients with asthma, requiring careful choice of inhaler device. However, the frequent presence of multiple pathology and multiple medication in this age group enhances the risk of adverse effects from oral preparations, and so the inhaled route should be preferred wherever possible. Underestimation of the severity of an acute exacerbation of asthma by both patient and doctor has been suggested as a contributory factor to poor outcome in older people. Since the cardiovascular responses to hypoxia and bronchoconstriction tend to diminish with increasing age, objective measures of asthma severity (peak flow monitoring and blood gas estimation) are essential in this age group.

Entities:  

Mesh:

Year:  1999        PMID: 10069405     DOI: 10.2165/00002512-199914010-00001

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  42 in total

Review 1.  Antileukotrienes in the treatment of asthma.

Authors:  P M O'Byrne; E Israel; J M Drazen
Journal:  Ann Intern Med       Date:  1997-09-15       Impact factor: 25.391

2.  The clinical outcome of asthma in the elderly: a 7-year follow-up study.

Authors:  S S Braman; W M Corrao; J T Kaemmerlen
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

3.  Candidiasis and dysphonia complicating beclomethasone treatment of asthma.

Authors:  J H Toogood; B Jennings; R W Greenway; L Chuang
Journal:  J Allergy Clin Immunol       Date:  1980-02       Impact factor: 10.793

4.  Age specific trends in asthma mortality in England and Wales, 1983-95: results of an observational study.

Authors:  M J Campbell; G R Cogman; S T Holgate; S L Johnston
Journal:  BMJ       Date:  1997-05-17

5.  Assessment of steroid responsiveness in patients with chronic airflow obstruction.

Authors:  T C Stokes; J M Shaylor; J F O'Reilly; B D Harrison
Journal:  Lancet       Date:  1982-08-14       Impact factor: 79.321

6.  Acute angle-closure glaucoma as a complication of combined beta-agonist and ipratropium bromide therapy in the emergency department.

Authors:  S K Hall
Journal:  Ann Emerg Med       Date:  1994-04       Impact factor: 5.721

7.  Predictors of major toxicity after theophylline overdose.

Authors:  M Shannon
Journal:  Ann Intern Med       Date:  1993-12-15       Impact factor: 25.391

8.  Lack of clinical exacerbations in adults with chronic asthma after immunization with killed influenza virus.

Authors:  B Stenius-Aarniala; J K Huttunen; R Pyhälä; T Haahtela; P Jokela; A Jukkara; T Karakorpi; M Kataja; T Kava; P Kuusisto
Journal:  Chest       Date:  1986-06       Impact factor: 9.410

9.  Comparisons of asthma, emphysema, and chronic bronchitis diagnoses in a general population sample.

Authors:  R Dodge; M G Cline; B Burrows
Journal:  Am Rev Respir Dis       Date:  1986-06

10.  Influence of age on response to ipratropium and salbutamol in asthma.

Authors:  M I Ullah; G B Newman; K B Saunders
Journal:  Thorax       Date:  1981-07       Impact factor: 9.139

View more
  2 in total

Review 1.  Zafirlukast: an update of its pharmacology and therapeutic efficacy in asthma.

Authors:  C J Dunn; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 2.  Optimal management of asthma in elderly patients: strategies to improve adherence to recommended interventions.

Authors:  Dianne P Goeman; Jo A Douglass
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.